Kaiser Family Foundation research found that 10 million people who are currently uninsured could be eligible for tax credits to help with purchasing a plan through an Affordable Care Act exchange, and an additional 7 million could be eligible for the Children's Health Insurance Program or Medicaid. Kaiser estimates that 27 million Americans lack health insurance, and about 12 million will get coverage through an ACA exchange this year.
New antiviral drugs for COVID-19 won't make a significant difference in efforts to reduce the pandemic's impact if patient access barriers cannot be overcome, experts say. The Biden administration is investing $650 million to expand production of rapid tests and promulgated a rule allowing pharmacists to prescribe, dispense and administer drugs for COVID-19, and other steps to reducing barriers could include allowing standing orders for the drugs and prescribing them as prevention for immunocompromised patients with suspected exposure.
The Department of Justice has asked the 6th US Circuit Court of Appeals to lift a court order issued earlier this month that blocks the Biden administration's COVID-19 vaccine requirement for businesses with at least 100 workers. The administration said the delay would result in more deaths, and it asked the court to allow requirements that unvaccinated employees use masks and be tested for COVID-19 while the litigation unfolds.
The FDA has given emergency use authorization to InBios International for its SCoV-2 Ag Detect rapid self-test, an over-the-counter at-home COVID-19 diagnostic test. The test uses anterior nasal swab samples collected by adults for children ages 2 to 13 years old and can be used by asymptomatic individuals.
Abbott Laboratories has signed a long-term lease for an 11.4-acre research and development site in South Portland, Maine. The facility will be used for laboratory analysis of raw materials that are used during pre-market studies of medical products. The lease's terms were not disclosed.
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for 266 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.
Contact PCMA Charles Cote
Vice President, Strategic Communications